Post-translational processing of the leukocyte integrin alpha 4 beta 1

J Biol Chem. 1992 Dec 15;267(35):25274-81.

Abstract

The leukocyte integrin alpha 4 beta 1 (VLA-4, CD49d/CD29) is a receptor for the extracellular matrix protein fibronectin and the endothelial adhesion protein VCAM-1. We have analyzed the biosynthesis and post-translational modifications of the two subunits of this receptor complex. The alpha 4 subunit was initially synthesized as a single-chain polypeptide that underwent the formation of complex endoglycosidase H-resistant oligosaccharide side chains and which could be proteolytically cleaved into two noncovalently associated fragments. The level and rate of alpha 4 subunit cleavage was dependent on the cell studied. The T cell tumor line HPB-ALL expressed both intact and fragmented alpha 4 on the cell surface. The interleukin-2-dependent natural killer line NK 3.3 and long term interleukin-2-dependent activated T lymphocytes cleaved the alpha 4 polypeptide earlier and more efficiently than did HPB-ALL cells and did not have detectable levels of intact alpha 4 on the cell surface. The proteolysis of alpha 4 was blocked by treating cells with either the lysosomotrophic amine NH4Cl or the carboxylic ionophore monensin. The presence of complex N-linked oligosaccharides did not seem to be necessary for alpha 4 cleavage or for binding of the alpha 4 beta 1 complex to a synthetic peptide corresponding to the binding site for this receptor on fibronectin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antibodies, Monoclonal
  • Epitopes / analysis
  • Fibronectins / metabolism
  • Glycoside Hydrolases / antagonists & inhibitors
  • Humans
  • Immunoblotting
  • Integrin alpha4beta1
  • Integrins / biosynthesis*
  • Integrins / genetics
  • Interleukin-2 / pharmacology
  • Leukocytes / physiology*
  • Macromolecular Substances
  • Molecular Sequence Data
  • Peptides / chemical synthesis
  • Peptides / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Protease Inhibitors / pharmacology
  • Protein Processing, Post-Translational*
  • Receptors, Very Late Antigen / biosynthesis*
  • Receptors, Very Late Antigen / genetics
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Epitopes
  • Fibronectins
  • Integrin alpha4beta1
  • Integrins
  • Interleukin-2
  • Macromolecular Substances
  • Peptides
  • Protease Inhibitors
  • Receptors, Very Late Antigen
  • Glycoside Hydrolases